Solara Active Pharma Sciences Limited — Board Meeting, 21-02-2025: Outcome of Board Meeting

The Board of Directors has made several key decisions during its recent meeting. They have approved the closure of Solara Active Pharma Sciences LTDA in Brazil due to inactivity. The Nomination and Remuneration Committee granted 3,50,000 Employee Stock Option Plan (ESOP) options to eligible employees at an exercise price of ₹375 per option. Additionally, Sandeep Rao has been appointed as the Managing Director and CEO for a three-year term, while Poorvank Purohit resigned from the same position. Sarat Kumar will take over as the Chief Financial Officer. Changes to the Risk Management, Corporate Social Responsibility, and Stakeholder Relationship Committees were also confirmed.